几种罕见的甲单元特异性肿瘤

doi:10.35541/cjd.20191108

摘要/Abstract

摘要： 【摘要】甲单元特异性肿瘤是一组罕见的仅发生于甲单元的肿瘤，包括甲乳头瘤、甲母质瘤、甲母质细胞瘤、甲母质细胞癌、甲鞘上皮癌等。由于其特殊的解剖位置，该类肿瘤都有着特异性的临床表现和病理学特征。本文重点阐述上述几种肿瘤的临床表现、组织病理特征及治疗等。

关键词: 肿瘤, 指（趾）甲, 病理过程, 甲乳头瘤, 甲母质瘤, 甲母质细胞瘤, 甲母质细胞癌, 甲鞘上皮癌

Abstract: 【Abstract】 Nail unit tumors are a group of rare tumors only occurring in the nail unit, including onychopapilloma, onychomatricoma, onychocytic matricoma, onycholemmal carcinoma and so on. These tumors have specific clinical manifestations and pathological features due to their special anatomical locations. This review focuses on clinical manifestations, histopathological characteristics and treatment of the above tumors.

Key words: Neoplasms, Nails, Pathologic processes, Onychopapilloma, Onychomatricoma, Onychocytic matricoma, Onychocytic carcinoma, Onycholemmal carcinoma

刘梦茜周园刘珍如王晓晴王大光. 几种罕见的甲单元特异性肿瘤[J]. 中华皮肤科杂志, 2021, 54(10): 920-923.doi:10.35541/cjd.20191108

Liu Mengxi, Zhou Yuan, Liu Zhenru, Wang Xiaoqing, Wang Daguang. Several rare nail unit tumors[J]. Chinese Journal of Dermatology, 2021, 54(10): 920-923.doi:10.35541/cjd.20191108

参考文献 31

［1］	Haneke E. Review of a recently delineated longitudinal lesion of the nail: onychopapilloma［J］. J Eur Acad Dermatol Venereol, 2018,32（11）:1839⁃1840. doi: 10.1111/jdv.15262.
［2］	王子洋, 杨希川. 甲良性肿瘤［J］. 皮肤科学通报, 2018,35（4）:446⁃452.
［3］	Tosti A, Schneider SL, Ramirez⁃Quizon MN, et al. Clinical, dermoscopic, and pathologic features of onychopapilloma: a review of 47 cases［J］. J Am Acad Dermatol, 2016,74（3）:521⁃526. doi: 10.1016/j.jaad.2015.08.053.
［4］	Tambe SA, Ansari SMM, Nayak CS, et al. Surgical management of onychopapilloma, onychomatricoma, and subungual osteochondroma: case series［J］. J Cutan Aesthet Surg, 2018,11（3）:143⁃147. doi: 10.4103/JCAS.JCAS_72_18.
［5］	Ito T, Uchi H, Yamada Y, et al. Onychopapilloma manifesting longitudinal melanonychia: a mimic of subungual malignancy［J］. J Dermatol, 2015,42（12）:1199⁃1201. doi: 10.1111/1346⁃8138.13097.
［6］	Haneke E. Important malignant and new nail tumors［J］. J Dtsch Dermatol Ges, 2017,15（4）:367⁃386. doi: 10.1111/ddg.13223.
［7］	Halteh P, Magro C, Scher RK, et al. Onychopapilloma presenting as leukonychia: case report and review of the literature［J］. Skin Appendage Disord, 2017,2（3⁃4）:89⁃91. doi: 10.1159/000448105.
［8］	Joo HJ, Kim MR, Cho BK, et al. Onychomatricoma: a rare tumor of nail matrix［J］. Ann Dermatol, 2016,28（2）:237⁃241. doi: 10. 5021/ad.2016.28.2.237.
［9］	Richert B, Lecerf P, Caucanas M, et al. Nail tumors［J］. Clin Dermatol, 2013,31（5）:602⁃617. doi: 10.1016/j.clindermatol.2013. 06.014.
［10］	Sanchez M, Hu S, Miteva M, et al. Onychomatricoma has channel⁃like structures on in vivo reflectance confocal microscopy［J］. J Eur Acad Dermatol Venereol, 2014,28（11）:1560⁃1562. doi: 10.1111/jdv.12269.
［11］	Cinotti E, Veronesi G, Labeille B, et al. Imaging technique for the diagnosis of onychomatricoma［J］. J Eur Acad Dermatol Venereol, 2018,32（11）:1874⁃1878. doi: 10.1111/jdv.15108.
［12］	Wang L, Gao T, Wang G. Nail bed onychomatricoma［J］. J Cutan Pathol, 2014,41（10）:783⁃786. doi: 10.1111/cup.12373.
［13］	Lesort C, Debarbieux S, Duru G, et al. Dermoscopic features of onychomatricoma: a study of 34 cases［J］. Dermatology, 2015,231（2）:177⁃183. doi: 10.1159/000431315.
［14］	Ocampo⁃Garza J, Di Chiacchio NG, Di Chiacchio N. Pigmented onychomatricoma: four cases［J］. Australas J Dermatol, 2018,59（1）:e66⁃e69. doi: 10.1111/ajd.12638.
［15］	Schneider SL, Tosti A. Tips to diagnose uncommon nail disorders［J］. Dermatol Clin, 2015,33（2）:197⁃205. doi: 10.1016/j.det.2014. 12.003.
［16］	Rushing CJ, Ivankiv R, Bullock NM, et al. Onychomatricoma: a rare and potentially underreported tumor of the nail matrix［J］. J Foot Ankle Surg, 2017,56（5）:1095⁃1098. doi: 10.1053/j.jfas. 2017.04.008.
［17］	Kallis P, Tosti A. Onychomycosis and onychomatricoma［J］. Skin Appendage Disord, 2016,1（4）:209⁃212. doi: 10.1159/000 445908.
［18］	Perrin C, Cannata GE, Langbein L, et al. Acquired localized longitudinal pachyonychia and onychomatrical tumors: a comparative study to onychomatricomas （5 cases） and onychocytic matricomas （4 cases）［J］. Am J Dermatopathol, 2016,38（9）:664⁃671. doi: 10.1097/DAD.0000000000000511.
［19］	d′Almeida L, Jeunon T, Leverone AP, et al. Onychocytic matricoma［J］. An Bras Dermatol, 2019,94（2）:214⁃216. doi: 10. 1590/abd1806⁃4841.20197865.
［20］	Spaccarelli N, Wanat KA, Miller CJ, et al. Hypopigmented onychocytic matricoma as a clinical mimic of onychomatricoma: clinical, intraoperative and histopathologic correlations［J］. J Cutan Pathol, 2013,40（6）:591⁃594. doi: 10.1111/cup.12122.
［21］	Song H, Qu F, Dang N, et al. Onychocytic matricoma: report of an asian case［J］. Ann Dermatol, 2017,29（3）:355⁃357. doi: 10. 5021/ad.2017.29.3.355.
［22］	Perrin C. Onychomatricoma micropapilliferum, a new variant of onychomatricoma: clinical, dermoscopical, and histological correlations （report of 4 cases）［J］. Am J Dermatopathol, 2020,42（2）:103⁃110. doi: 10.1097/DAD.0000000000001440.
［23］	Perrin C. Tumors of the nail unit. A review. Part II: acquired localized longitudinal pachyonychia and masked nail tumors［J］. Am J Dermatopathol, 2013,35（7）:693⁃709. doi: 10.1097/DAD. 0b013e318293f387.
［24］	Perrin C, Cannata GE, Ambrosetti D, et al. Acquired localized （monodactylous） longitudinal pachyonychia and onychocytic carcinoma in situ （2 cases）: part II［J］. Am J Dermatopathol, 2017,39（1）:40⁃44. doi: 10.1097/DAD.0000000000000579.
［25］	周园, 陈韡, 王大光. 甲恶性肿瘤的诊疗进展［J］. 中华皮肤科杂志, 2018,51（10）:776⁃778. doi: 10.3760/cma.j.issn.0412⁃4030. 2018.10.023.
［26］	Wang L, Gao T, Wang G. Invasive onychocytic carcinoma［J］. J Cutan Pathol, 2015,42（5）:361⁃367. doi: 10.1111/cup.12476.
［27］	Alessi E, Coggi A, Gianotti R, et al. Onycholemmal carcinoma［J］. Am J Dermatopathol, 2004,26（5）:397⁃402. doi: 10.1097/00000372⁃200410000⁃00010.
［28］	Chaser BE, Renszel KM, Crowson AN, et al. Onycholemmal carcinoma: a morphologic comparison of 6 reported cases［J］. J Am Acad Dermatol, 2013,68（2）:290⁃295. doi: 10.1016/j.jaad. 2012.07.015.
［29］	Han B, Lee CH, Han TY, et al. A case of onycholemmal carcinoma in a 77⁃year⁃old man［J］. Am J Dermatopathol, 2017,39（11）:874⁃875. doi: 10.1097/DAD.0000000000000770.
［30］	Maffeis V, Salmaso R, Cappellesso R, et al. Onycholemmal carcinoma: a case report with its molecular profiling［J］. J Cutan Pathol, 2018,45（6）:463⁃465. doi: 10.1111/cup.13135.
［31］	Inaoki M, Makino E, Adachi M, et al. Onycholemmal carcinoma［J］. J Cutan Pathol, 2006,33（8）:577⁃580. doi: 10.1111/j.1600⁃0560.2006.00482.x.

[1]	吴煜昊张国龙王秀丽. 三级淋巴结构在恶性黑素瘤中的研究进展[J]. 中华皮肤科杂志, 2021, 54(9): 827-830.
[2]	刘倩李国宏陈炳为. 非黑素瘤皮肤癌患者生活质量及影响因素调查[J]. 中华皮肤科杂志, 2021, 54(9): 819-821.
[3]	王逸飞耿怡缪秋菊宋昊徐秀莲孙建方. 黏蛋白痣10例临床病理分析[J]. 中华皮肤科杂志, 2021, 54(9): 804-807.
[4]	张晓付萌王雷刘宇高天文刘玲. 临床误诊的皮肤黑素瘤118例分析[J]. 中华皮肤科杂志, 2021, 54(9): 771-776.
[5]	陈凤鸣亢寒梅高天文付萌王雷刘玲. 先天性色素痣伴增生性结节10例临床病理分析[J]. 中华皮肤科杂志, 2021, 54(9): 785-789.
[6]	郭伟赵涛郭伟楠马翠玲高天文赵建红李冰. 早期甲黑素瘤115例手术治疗方案和预后回顾分析[J]. 中华皮肤科杂志, 2021, 54(9): 777-784.
[7]	王大光蒋佳怡. 几种甲病诊疗的思考[J]. 中华皮肤科杂志, 2021, 54(8): 733-737.
[8]	李婷徐明圆吴飞梁豫琳刘业强. 204例皮角患者组织病理与临床分析[J]. 中华皮肤科杂志, 2021, 54(8): 677-682.
[9]	高飞谈园马乐黄敖张帅罗宏. 新西兰兔感染梅毒螺旋体体内扩散模型构建[J]. 中华皮肤科杂志, 2021, 54(8): 702-704.
[10]	中华医学会皮肤性病学分会皮肤肿瘤研究中心中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤鳞状细胞癌诊疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(8): 653-664.
[11]	虞英媛李影余增洋郑建锋张希琳丁杨峰史玉玲. 英夫利西单抗治疗重度斑块状银屑病的疗效和安全性及其对PD-1、PD-L1表达的影响[J]. 中华皮肤科杂志, 2021, 54(7): 590-596.
[12]	杨长志张晓萍杨子良周乃慧朱丽萍邵凯朱婷婷余秀琴. 成人皮肌炎患者抗核抗体与临床特征及肿瘤风险的关系[J]. 中华皮肤科杂志, 2021, 54(6): 480-484.
[13]	韩晓锋孙娟徐教生马琳. 儿童脑回状皮脂腺痣14例临床分析[J]. 中华皮肤科杂志, 2021, 54(6): 529-531.
[14]	刘洋朱月倩孙祺琳王雪陈骏刘科. 全甲板撕脱术治疗五例逆生性甲的疗效评估[J]. 中华皮肤科杂志, 2021, 54(6): 532-534.
[15]	郭清清宋亚丽. 手足口病12例甲损害临床与皮肤镜表现[J]. 中华皮肤科杂志, 2021, 54(5): 431-433.